Drug Trial Radar · NCT07310927
Alginate vs Sucralfate for GERD Symptomatic Relief
Last checked: Nov 20, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
140
Actual
Start
Apr 1, 2025
Primary completion
Apr 30, 2026
Study completion Jul 13, 2026
Sponsor
- Lead sponsor
- CMH Lahore Medical College and Institute of DentistryAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Gastroesophageal reflux disease (GERD) is a chronic gastrointestinal disorder characterized by the regurgitation of gastric contents into the esophagus.It can also present in an atypical manner such as chest pain, dental erosions, chronic cough, laryngitis, or asthma i.e. extra gastroesophageal symptoms. Sucralfate is a unique anti-ulcer drug and is a basic aluminum salt of sucrose octa-sulfate. It forms a protective layer, enhancing bicarbonate production, demonstrating anti-peptic properties, and fostering tissue growth, regeneration, and repair and it undergoes minimal enteral reabsorption. Alginate is a naturally occurring anionic polymer typically obtained from brown seaweed and has been extensively investigated and used for many biomedical applications, due to its biocompatibility, low toxicity, relatively low cost, and mild gelation by addition of divalent cations such as Ca2+.Both sucralfate and alginate have been in use for the treatment and symptomatic relief of GERD and are well tolerated oral formulations.
Conditions
- GERD
Interventions
AlginateDrug
2 Table spoon spoon suspension syrup twice a day before meal.
SucralfateDrug
2 Table spoon spoon suspension syrup twice a day before meal.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Quality of Life in Reflux and DyspepsiaTime frame: Before Treatment, At 4 weeks, At 6 Weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cmh Lahore
Lahore, Punjab Province, Pakistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.